Apimeds Pharmaceuticals US, Inc. Common Stock (APUS)

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) through its wholly owned subsidiary MindWave Innovations Inc., is featured in the latest CryptoCurrencyWire Audio Production released by IBN. During the interview with IBN’s Carmel Fisher, MindWave CEO Dr. Vin Menon discusses the development of MindChain, an institutional blockchain platform designed to combine digital asset infrastructure with insurance protection. Menon outlines the subsidiary’s efforts to establish enterprise blockchain ecosystems across multiple industries, including climate technology, media and advertising, and insurance. These initiatives include a ClimateTech partnership with AQUAE Impact, an AdTech agreement involving a Nasdaq-listed company and an InsurTech ecosystem under development to integrate insurance claims and reinsurance processing into smart contracts.

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) through its wholly owned subsidiary MindWave Innovations Inc., is featured in the latest CryptoCurrencyWire Audio Production released by IBN. During the interview with IBN’s Carmel Fisher, MindWave CEO Dr. Vin Menon discusses the development of MindChain, an institutional blockchain platform designed to combine digital asset infrastructure with insurance protection. Menon outlines the subsidiary’s efforts to establish enterprise blockchain ecosystems across multiple industries, including climate technology, media and advertising, and insurance. These initiatives include a ClimateTech partnership with AQUAE Impact, an AdTech agreement involving a Nasdaq-listed company and an InsurTech ecosystem under development to integrate insurance claims and reinsurance processing into smart contracts.

MindWave Innovations (NYSE American: APUS) was featured in a recent article that discussed how growing blockchain adoption is increasing demand for specialized infrastructure to support complex digital asset applications and how the company is positioning itself in this evolving market. “Rather than building around a single application or token, MindWave’s newly defined ecosystem is structured around four interconnected components: MindWave as the infrastructure provider, MindChain as the underlying blockchain, MindWaveDAO as the community and governance layer, and $NILA as the utility and governance token,” the publication reads. “At the center is MindChain, an EVM-compatible Layer 2 designed to serve as the shared blockchain foundation for the ecosystem. The network uses Ethereum as its settlement and finality anchor while incorporating validator infrastructure, bridges, developer tooling and application-specific network capabilities.”

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that NILA, the native utility and governance token of the MindChain network developed by its wholly owned subsidiary, MindWave Innovations Inc. USA, is scheduled to begin trading on the Pionex cryptocurrency exchange Oct. 14, 2026, at 6 a.m. Eastern time. The listing will make NILA available to eligible users through the NILA/USDT trading pair, with access to Pionex’s standard trading features and automated trading tools. The listing expands international access to NILA ahead of its planned migration to MindChain, an Ethereum-based Layer 2 network designed to support enterprise blockchain applications. MindWave has recently signed agreements to develop three dedicated networks — AQUAEChain, FlashChain and AssureChain — on MindChain. Following the network’s launch, NILA is designed to support transaction fees, staking and network security, subject to applicable regulatory and technical requirements.

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) through its wholly owned subsidiary MindWave Innovations Inc. USA, announced that MindWave signed three agreements between Sept. 24 and Oct. 4, 2026, to build and operate dedicated blockchain networks on its MindChain infrastructure for clients in climate finance, sports media and insurance. The agreements include Singapore-based AQUAE Holdings for its AQUAEChain environmental credit platform, New York-based Flash Sports & Media Holdings for its FlashChain digital ticketing and media authentication network and Delaware-based BlockAssure for its AssureChain insurance and reinsurance network. Under the agreements, MindWave will receive contracted fees or equity along with allocations equal to 20% of the applicable credits or tokens, providing opportunities for recurring revenue as the networks become operational.

Many blockchain ecosystems rely heavily on token issuance and community funding to support development. A project issues a token, sells some of it and hopes enough demand develops to support the ecosystem as products and services are built. While that model has helped fund blockchain projects, it can also create challenges when token prices decline or investor sentiment changes. MindWave Innovations (NYSE American: APUS) is developing a different approach. The company is developing a Layer 2 blockchain called MindChain and an ecosystem around it, MindWaveDAO, organized around commercial sectors such as digital advertising, climate credits and real-world asset tokenization rather than purely speculative token activity.

Blockchain adoption has increasingly moved beyond the question of whether businesses can use digital assets. The more important question is what infrastructure can support those applications as they become more complex and specialized.

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) subsidiary MindWave Innovations Inc. USA signed a two-year master maintenance and service agreement with BlockAssure Inc. to build, deploy and operate AssureChain, a dedicated subnet of MindChain for BlockAssure insurance and reinsurance operations. MindWave will design, develop, security-audit and deploy AssureChain, then host, operate and maintain the network, which will support contracts, policies, premium and payment entries, reinsurance treaties and claims processing. MindChain will provide the settlement layer and anchor AssureChain records to Ethereum.

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) subsidiary MindWave Innovations Inc. USA signed a two-year master maintenance and service agreement with BlockAssure Inc. to build, deploy and operate AssureChain, a dedicated subnet of MindChain for BlockAssure insurance and reinsurance operations. MindWave will design, develop, security-audit and deploy AssureChain, then host, operate and maintain the network, which will support contracts, policies, premium and payment entries, reinsurance treaties and claims processing. MindChain will provide the settlement layer and anchor AssureChain records to Ethereum.

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that its wholly owned subsidiary, MindWave Innovations Inc., signed a 12-month software development and technology services agreement with Flash Sports & Media Holdings, Inc. to build and operate FlashChain, a blockchain designed to track digital broadcasting rights, video assets and match ticket inventory. MindWave will deploy a dedicated FlashChain subnet on its MindChain Layer-2 infrastructure, operate validator nodes and develop software connecting Flash streaming and ticketing platforms and gate-scanning hardware to the network.

Dallas TX - Sept. 24, 2026 - Investors are watching DarkHorse Technologies Inc. (NASDAQ: DRK), Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), Greenland Energy Company (NASDAQ: GLND) and Glucotrack, Inc. (NASDAQ: GCTK) as new developments span AI data centers, digital infrastructure, Greenland energy exploration and biotechnology financing .

DALLAS TX - Sept. 24, 2026 - DarkHorse Technologies Inc. (NASDAQ: DRK) is advancing its transformation into an AI infrastructure and high-performance computing (HPC) data center company, adding four strategic partners to support the conversion and development of its power and data center assets across the Tennessee Valley Authority (TVA) region.